dc.contributor.author
Lapeña, Pau
dc.contributor.author
Urra, Xabier
dc.contributor.author
Llopis, Jaume
dc.contributor.author
Hernández-Meneses, Marta
dc.contributor.author
Cuervo Requena, Guillermo
dc.contributor.author
Maisterra, Olga
dc.contributor.author
Escrihuela Vidal, Francesc
dc.contributor.author
Prats-Sánchez, Luis
dc.contributor.author
Sáez, Carmen
dc.contributor.author
Olmos, Carmen
dc.contributor.author
Hernández-Fernández, Francisco
dc.contributor.author
Werner, Mariano
dc.contributor.author
Pérez de la Ossa, Natalia
dc.contributor.author
Quintana, Eduard
dc.contributor.author
Moreno Camacho, Ma. Asunción
dc.contributor.author
Chamorro Sánchez, Ángel
dc.contributor.author
Miró Meda, José M. (José María), 1956-
dc.contributor.author
Mechanical Thrombectomy in IE Investigators
dc.contributor.author
Cat-SCR Consortium
dc.date.issued
2026-01-28T17:46:57Z
dc.date.issued
2026-02-06T06:10:20Z
dc.date.issued
2025-02-07
dc.date.issued
2026-01-28T17:46:57Z
dc.identifier
https://hdl.handle.net/2445/226367
dc.description.abstract
Objectives: Acute ischaemic strokes (stroke) are frequent and severe extracardiac complications in infective endocarditis (IE). Because intravenous thrombolysis (i.v.-thrombolysis) is contraindicated, mechanical thrombectomy (thrombectomy) offers potential benefits. We aimed to compare thrombectomy efficacy and safety between IE-related and general stroke cases.
Methods: Multicentre study of consecutive IE cases treated with thrombectomy at nine stroke centres in Spain from 2011 to 2022. Using propensity score matching, 50 IE cases were 1:4 matched with patients without IE stroke (n = 200). Efficacy was defined by successful recanalization rates (modified treatment in cerebral ischaemia scale ≥2 b), neurological improvement at 24 hours (decrease of National Institutes of Health Stroke Scale compared with baseline), and good neurological outcome rates at 3 months (modified Rankin scale ≤2). Safety was assessed by intracranial haemorrhage (IC-haemorrhage), symptomatic IC-haemorrhage, crude mortality, and stroke-related mortality.
Results: Among 54 IE cases, 50 were matched with 200 controls. Successful recanalization was similarly achieved in both groups (76% vs. 83%). Median National Institutes of Health Stroke Scale at 24 hours was comparable, with analogous rates of neurological improvement (78% vs. 78%), and early dramatic response (48% vs. 46.5%). No differences were seen regarding IC-haemorrhage rates, except for when prior i.v.-thrombolysis was given. Although crude mortality was higher in the IE cohort, no differences were seen in stroke-related mortality (12% vs. 15%). At 3 months, modified Rankin scale scores of the two groups were superimposable.
Discussion: Thrombectomy in IE is as effective and safe as in patients without IE, and prior i.v.-thrombolysis could decrease the procedural safety. Clinical practice guidelines may consider including the recommendation to perform thrombectomy alone in IE-related stroke.
dc.format
application/pdf
dc.publisher
European Society of Clinical Microbiology and Infectious Diseases
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.cmi.2025.02.008
dc.relation
Clinical Microbiology and Infection, 2025, vol. 31, num.8, p. 1321-1329
dc.relation
https://doi.org/10.1016/j.cmi.2025.02.008
dc.rights
(c) Lapeña, P. et al., 2025
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Embòlia i trombosi cerebral
dc.subject
Complicacions (Medicina)
dc.subject
Cerebral embolism and thrombosis
dc.subject
Complications (Medicine)
dc.title
Efficacy and Safety of Mechanical Thrombectomy in Acute Ischemic Stroke Secondary to Infective Endocarditis
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion